T2D
13
1
3
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
15%
2 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (13)
Potatoes, Type 2 Diabetes, and Cardiometabolic Health
Prevalence of NAFLD in T2DM Patients
Fitbit and AI Chatbot in Sedentary Primary Care Patients With T2D
A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both
A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1)
Embecta AID System in Adults With Type 2 Diabetes
Clinical Study on Exploring High Risk Factors Inducing the Progress of Diabetes
Study on the Efficacy and Safety of Chiglitazar Sodium in PCOS With T2DM
Pathogenesis of Youth Onset Type 2 Diabetes and Prediabetes
The Role of Traditional or Western Diet in the TBC1D4 Gene on Glucose Homeostasis in Greenland Inuits
BM-MNC and UCMSC for Type 2 Diabetes Mellitus Patients
Peanut Consumption and Cardiovascular Disease Risk in a Chinese Population